Introduction {#S0001}
============

Fever and pain, either presenting individually or together, constitute major modulators of illness-related outcomes in pediatric medicine. Chronic pain affects 11--38% of children,[@CIT0001] and nearly 40% of children and adolescents complain of pain that occurs at least once weekly.[@CIT0002],[@CIT0003] Management of pain and/or fever in children is an important responsibility of physicians, and proper care results in reducing distress, treating underlying illnesses, and avoiding inappropriate medication.[@CIT0004]

Pain experienced by children is a common outcome of injury, illness, or medical procedures and is a result of a complex interaction between sensory, emotional, cognitive, and behavioral components which are modulated by multidimensional factors, such as environmental, developmental, and sociocultural factors.[@CIT0004]--[@CIT0006] Thus, our understanding of pain and the resultant suffering must transcend narratives focusing on sensory experiences, especially in pediatric patients where pain negatively impacts the overall health-related quality of life and is associated with poorer outcomes and psychological distress in both children and their primary caregivers -- their parents.[@CIT0007]--[@CIT0009]

As per the Joint Commission on Accreditation of Healthcare Organizations standards, pain is deemed as "the fifth vital sign," and caregivers are required to periodically monitor and address pain.[@CIT0002],[@CIT0010] However, its undertreatment in a substantial percentage of children has been well-documented.[@CIT0011] While a multidimensional approach to assessing care (including self-reports, behavioral, and physiological indicators) is considered necessary owing to the subjective nature of pain, a variety of age-sensitive tools are available for the assessment of pain in pediatrics, namely, facial expression-based scales such as the Neonatal Facial Coding Scale, the Children's Revised Impact of Event Scale, the Verbal Rating Scale (VRS), and others. Appropriate management of pain in clinical settings, however, faces several barriers. According to the American Academy of Pediatrics, some of the barriers include 1) the myth that children, especially infants, do not feel pain the way adults do, or if they do, there is no untoward consequence; 2) lack of assessment and reassessment for the presence of pain; 3) misunderstanding of how to conceptualize and quantify a subjective experience; 4) lack of knowledge of pain treatment; 5) the notion that addressing pain in children takes too much time and effort; and 6) fears of adverse effects of analgesic medications, including respiratory depression and addiction with opioids.[@CIT0004] Written guidelines and protocols advocating the appropriate use of environmental, behavioral, and pharmacological interventions are important for the rational management of pediatric pain and will lead to the avoidance of inappropriate practices like sedation, which does not provide pain relief and may mask the response to pain.[@CIT0012]

Fever, one of the most common symptoms of illness in children, is seen in 19--30% of patients in office-based pediatric practice.[@CIT0013],[@CIT0014] In a retrospective cohort study conducted among 5000 children in pediatric primary care practice, there were a total of 0.84 visits with fever ≥38°C per child per year and 0.24 visits per child per year with fever ≥39°C. These figures reflect the frequency of fever as a presentation of illnesses in children.[@CIT0015] Fever is not primarily an illness in itself but is rather a physiologic mechanism that plays an important role in fighting infection. Thus, when treating a febrile child, the focus should be on improving the child's overall comfort rather than on normalizing the body temperature.[@CIT0016] Due to a perceived "fever phobia" and the concern that a child must maintain a "normal" temperature, several parents administer antipyretics even when the fever is minimal or absent.[@CIT0016] In a 13-question survey study of caregivers, none of the surveyed parents were able to appropriately define fever, and yet 93% mistakenly believed that high fever can cause brain damage.[@CIT0017]

In view of the importance of the appropriate management of fever/pain in pediatric patients, meticulous documentation of their management practices could help in identifying shortcomings in current practices and formulating better treatment modalities. The main objective of this study was to evaluate the prescription patterns of analgesics, antipyretics, and NSAIDs in children with fever and/or acute pain presenting for medical care in different Latin American, African, and Middle Eastern countries.

Methods {#S0002}
=======

Study design and participants {#S0002-S2001}
-----------------------------

This was a multinational, multicenter, non interventional, cross-sectional study conducted in Latin America and the Caribbean (Costa Rica, Salvador, Honduras, Panama and Trinidad and Tobago grouped in one region -- Central America and the West Indies, Argentina, Mexico, and Venezuela), the Middle East (Algeria, Egypt, Iran, and Lebanon), and Africa (Senegal). All necessary regulatory submissions were ensured as per local regulations.

The target population for this study was patients between the ages of 3 months and 16 years; patients with fever and/or acute pain; and patients who attended outpatient clinics or hospital emergency departments and who were prescribed analgesics, antipyretics, and NSAIDs by attending physicians. Fever was defined as a central body temperature ≥38°C (without intense activity) in a child normally covered and at room temperature. Fever was measured using an electronic (rectal, oral, or axillary) thermometer or an infrared or liquid crystal thermometer. For the purpose of the study, acute pain was defined as any, mild, moderate, or severe pain of various origins, with a duration ≤6 weeks. Pain was evaluated using a validated scale adapted to the children's age: 1) a behavioral scale for children between 6 months and 4 years of age; 2) a facial expression scale or the VRS for children aged between 5 and 12 years; and 3) the VRS for children between 13 and 15 years. Patients who were currently participating or had recently participated in any other study and who were unable or unwilling to give consent were excluded.

Patients who met eligibility criteria and provided informed consent were recruited by physicians at different investigation sites that were selected on the basis of the geographical location of the site within the country and the patient population served. Each physician enrolled 10--15 patients. Patients were selected using simple random sampling.

Data collection {#S0002-S2002}
---------------

The data were collected by two methods in one single visit: a physician-administered questionnaire and case report forms. A structured, self‑reported questionnaire administered to the participating physicians was first developed in English, and it was translated into the local languages and back-translated into English by a blinded translator for ascertaining validity. The pre tested questionnaire was designed to assess the current practices in the diagnosis and management of children with fever and/or acute pain. The 21-item questionnaire also inquired about physicians' demographic and professional characteristics, the perceived reasons for unsatisfactory effect of pain/fever treatment, and the unmet needs in the management of fever and pain.

The information that was collected on standardized case report forms included patients' demographic and anthropometric characteristics; their medical history; the etiology, characteristics (duration and body temperature) and management (non pharmacological and pharmacological) approaches of fever; and the etiology, characteristics (duration and intensity), and management (non pharmacological and pharmacological) approaches of acute pain.

Outcomes {#S0002-S2003}
--------

Primary outcomes were the most commonly prescribed antipyretic and analgesic medications during both previous and current consultations; the most commonly used tools to assess fever and acute pain; and the proportion of children using non pharmacological methods for the management of fever and acute pain. Physicians' perceptions regarding the reasons for unsatisfactory effects of acute pain/fever treatment and the unmet needs in the management of acute pain and/or fever, as well as the characteristics of febrile and acute pain episodes were secondary outcomes.

Sample size estimation and statistical analysis {#S0002-S2004}
-----------------------------------------------

Since this study aimed to describe the real-world treatment patterns in pediatric patients with fever and/or acute pain, most findings were reported as proportions. To detect a proportion of 50%, at a 95% CI with the maximum marginal error of estimate not exceeding 7%, a sample size of 196 patients in each study country was estimated as appropriate. Assuming that data might not be available for 15--20% of patients, the estimated number of patients in each country was 240.

Data were analyzed separately according to the reported illness (patients with fever, patients with acute pain, and patients with both fever and acute pain), and according to age (between 3 and 24 months, between 2 and 6 years, between 6 and 12 years, and between 12 and 16 years). A descriptive analysis of the categorical variables was presented as counts and percentages, and continuous variables were presented as mean and SD. Data were statistically analyzed by using the non parametric Kruskal--Wallis test (for quantitative variables), the Chi-squared test, or Fisher's exact test (for qualitative variables), as appropriate. All tests were two-sided, and a *p*-value \<0.05 was considered significant. Statistical analyses were conducted using SAS 9.3 (SAS Institute Inc., Cary, NC, USA).

Ethics approval and informed consent {#S0002-S2005}
------------------------------------

This study was approved by the Ministry of Higher Education, Research and Innovation (France). Ethics approvals were obtained from the local institutional review committee of each participating center, and the legal guardians of all participants gave written informed consent. Every effort was made to ensure protocol standardization and adherence, including translation of the questionnaire into languages specific to each region, on-site monitoring, and centralized database management. This study was conducted in accordance with the Declaration of Helsinki and the Good Epidemiological Practice.

Results {#S0003}
=======

From September 2010 to September 2011, a total of 178 physicians, all of whom completed the questionnaire, participated in the study; two (one in Egypt and one in Mexico) did not recruit any patients. In total, 2125 patients were recruited; 8 patients were excluded due to major deviations, resulting in 2117 patients whose data were analyzed ([[Table S1](https://www.dovepress.com/get_supplementary_file.php?f=168140.pdf)]{.ul}).

The mean ± SD duration of clinical practice of physicians was 20.3±8.7 years. The majority (n=144; 80.9%) of the physicians were pediatricians.

Patient characteristics {#S0003-S2001}
-----------------------

The mean ± SD age of the patients was 4.4±3.8 years, most of whom (n=1576; 74.4%) were \>6 years old, and only 5.9% were between 12 and 16 years. There was a slight gender imbalance (overall 54% boys), with significant differences in gender between the age groups (*p*=0.0039). The majority (92.2%) of the patients lived in an urban environment ([Table 1](#T0001){ref-type="table"}). Upper and lower respiratory tract infections (RTIs) were the most frequently reported past (in 36.0% of the patients for upper and 13.1% for lower RTIs) and present (in 15.8% of the patients for upper and 5.7% for lower RTIs) medical conditions ([[Tables S2](https://www.dovepress.com/get_supplementary_file.php?f=168140.pdf)]{.ul}--[[S3](https://www.dovepress.com/get_supplementary_file.php?f=168140.pdf)]{.ul}).Table 1Demographics and patient characteristics3 to 24 months (N=702)2 to 6 years (N=874)6 to 12 years (N=415)12 to 16 years (N=126)Total number of analyzed patients (N=2117)Age (years) Mean (± SD)1.05 (±0.45)3.7 (±1.1)8.6 (±1.8)14.2 (±1.7)4.4 (±3.8)Gender (*p*=0.0039) Male; n (%)408 (58.1)454 (51.9)204 (49.2)78 (61.9)1144 (54.0) Female; n (%)294 (41.9)420 (48.1)211 (50.8)48 (38.1)973 (46.0)Housing location (*p*=0.2536) Urban; n (%)636 (90.6)814 (93.1)386 (93.0)115 (91.3)1951 (92.2) Rural; n (%)66 (9.4)60 (6.9)29 (7.0)11 (8.7)166 (7.8)Body temperature (°C; *p*\<0.0001) Mean (± SD)38.7 (±0.7)38.6 (±0.8)38.4 (±1.0)38.2 (±1.0)38.6 (±0.8)Weight (kg) Mean (± SD)9.5 (±2.3)15.7 (±3.8)28.3 (±9.4)48.4 (±12.5)18.0 (±11.7)Height (cm) Mean (± SD)74.5 (±9.3)98.7 (±10.9)128.3 (±12.9)154.2 (±14.7)99.8 (±25.9)BMI (kg/m^2^; *p*\<0.0001) Mean (± SD)17.1 (±2.7)16.0 (±2.3)16.9 (±3.6)20.3 (±4.6)16.8 (±3.1)[^1]

Fever {#S0003-S2002}
-----

Of the patients (n=2117) whose data were analyzed, 1856 (87.7%) had fever (central body temperature ≥38°C). The proportion of patients with fever significantly (*p*\<0.0001) decreased with age (668/702 \[95.2%\] in the age range 3--24 months; 784/874 \[89.7%\] in the age range 2--6 years; 322/415 \[77.6%\] in the age range 6--12 years, and 82/126 \[65.1%\] in the age range 12--16 years). The mean ±SD duration of the current episode of fever was 2.1±1.9 days, and RTIs represented the most commonly reported cause of fever (in 1334/1856 \[71.9%\] of febrile patients). Body temperature was significantly different according to the underlying disease (*p*=0.0009; Kruskal--Wallis test). [[Table S4](https://www.dovepress.com/get_supplementary_file.php?f=168140.pdf)]{.ul} summarizes the characteristics (etiology and duration) of the current episode of fever in different age groups. Of note, electronic thermometer was the most widely used diagnostic tool by physicians (73/178; 41.0%), followed by the mercury thermometer (62/178; 34.8%). Temperature was most often taken using the axillary route (38/100; 38.0%).

Treatment patterns were distinguished on the basis of whether antipyretics and non pharmacological approaches had been previously prescribed before the current consultation (previous treatment) or prescribed during the current consultation (current treatments). [Table 2](#T0002){ref-type="table"} summarizes the previous and current treatments prescribed to patients with fever.Table 2Previous and current treatments prescribed to patients with fever (N=1856)Treatment prescribed; n (%)PreviousCurrent**Non-pharmacological; N15161817** Warm water bath512 (33.8)627 (34.5) Remove excess clothing and linens419 (27.6)706 (38.9) Administrate oral hydration frequently387 (25.5)888 (48.9) Bed rest159 (10.5)302 (16.6) Ventilate room131 (8.6)311 (17.1) Other83 (5.5)86 (4.7)**Pharmacological; N15161817** Paracetamol/acetaminophen1073 (70.8)1165 (64.1) NSAIDs544 (35.9)851 (46.8) Metamizole61 (4.0)77 (4.2) Aspirin19 (1.3)7 (0.4)[^2]

Overall, 1516 of 1843 analyzed patients with fever (82.3%) had been previously advised non pharmacological treatment concomitantly with a pharmacological treatment. Significant age-related differences were observed in the prescription of the removal of excess clothing and linens (*p*=0.0017; more frequently used in younger children) and bed rest (*p*\<0.0001; more frequently used in older patients) ([[Table S5](https://www.dovepress.com/get_supplementary_file.php?f=168140.pdf)]{.ul}) during previous consultations. The most frequently prescribed antipyretic medications during previous consultations were paracetamol/acetaminophen (1073/1516; 70.8%) and NSAIDs (544/1516; 35.9%). Few adverse events (10/1073; 0.9% of the patients) related to a previous treatment with paracetamol were reported.

Treatments were prescribed to 1817/1856 patients (97.9%) during the current consultation (current treatment). Younger children were advised removal of excess clothing and linens significantly more often (*p*\<0.0001) than older children and older patients were advised bed rest (*p*\<0.0001 compared to younger children). The most commonly prescribed current medication for fever was paracetamol/acetaminophen (1165/1817; 64.1%). There was a significant difference between age groups for the use of paracetamol/acetaminophen during the current consultation (*p*\<0.0001). Although paracetamol/acetaminophen was most commonly prescribed in all age groups, it was given slightly more frequently in the 3--24 months (74.7%) and the 12--16 years (61.3%) age groups than in the 2--6 years (57.9%) and 6--12 years (58.0%) age groups.

For both previous and current treatments, syrup formulation was the most commonly prescribed pharmaceutical form of paracetamol/acetaminophen in children aged \<12 years and tablets in those ≥12 years.

No laboratory test was prescribed to most patients with fever (1169/1856; 63.0%). Complete blood count was the most frequently prescribed laboratory test (488/1856; 26.3%) in all age groups.

Pain {#S0003-S2003}
----

One-third (705/2117; 33.3%) of the analyzed patients had acute pain (duration ≤6 weeks), of which the most frequent cause was abdominal pain reported in 24.3% of patients. The proportion of patients with pain significantly increased with age (106/702 \[15.1%\] in the age range 3--24 months, 292/874 \[33.4%\] in the age range 2--6 years, 218/415 \[52.5%\] in the age range 6--12 years, and 89/126 \[70.6%\] in the age range 12--16 years; *p*\<0.0001) ([[Table S6](https://www.dovepress.com/get_supplementary_file.php?f=168140.pdf)]{.ul}). The mean ± SD duration of the episode of pain was significantly longer in older patients (1.7±1.5 days in the age range 3--24 months versus 3.3±5.4 days in the age range 12--16 years; *p*=0.0132). The most commonly used method to estimate pain intensity was the observation of behavioral changes (in 238/705 or 33.8% of the patients); the observation of behavioral changes and the analysis of physiological signals (used in 51/705 or 7.2% of the patients) were significantly less used in older patients (*p*\<0.0001 for behavioral changes and *p*=0.006 for physiological signals). The use of the VRS, the VAS, and the Numerical Rating Scale (NRS) for pain intensity estimation increased with age (*p*\<0.0001 for VRS and NRS and *p*=0.016 for VAS); in 159 patients (22.6%), no instrument was used to evaluate pain intensity ([[Table S7](https://www.dovepress.com/get_supplementary_file.php?f=168140.pdf)]{.ul}).

A total of 471/701 analyzed patients (67.2%) received a previous treatment for pain and 659/702 (93.9%) received current treatment. Among the non pharmacological measures used to alleviate pain, bed rest was the most frequently prescribed measure during both previous (103/471; 21.9%) and current (176/659; 26.7%) consultations. Significant age-group differences were observed in the recommendation of massages (*p*=0.0271; more often used in the age range 3--24 months) and deep breath/relaxation (*p*=0.0316; more often used in the age range 12--16 years) during previous consultations and in the prescription of bed rest during the current consultation (*p*=0.0046; prescribed less often in age range 3--24 months) ([[Table S8](https://www.dovepress.com/get_supplementary_file.php?f=168140.pdf)]{.ul}).

The most frequently prescribed analgesic during previous consultations was paracetamol/acetaminophen (253/471; 53.7%); codeine was only used in two patients aged ≥12 years. NSAIDs (364/659; 55.2%) and paracetamol/acetaminophen (251/659; 38.1%) were the most frequently prescribed pharmacological treatments during the current consultation. For both previous and current treatments, syrup was the most commonly prescribed pharmaceutical form in children aged \<12 years and tablets in those aged ≥12 years. [Table 3](#T0003){ref-type="table"} summarizes the current and previous treatments received by patients experiencing acute pain.Table 3Previous and current treatments prescribed to patients with acute pain (N=705)Treatment prescribed; n (%)PreviousCurrent**Non-pharmacological, N471659** Bed rest103 (21.9)176 (26.7) Other41 (8.7)66 (10.0) Massages22 (4.7)25 (3.8) Heat15 (3.2)18 (2.7) Cold13 (2.8)28 (4.2) Distraction8 (1.7)17 (2.6) Plays6 (1.3)14 (2.1) Deep breath/relaxation3 (0.6)5 (0.8) Ultrasound1 (0.2)5 (0.8)**Pharmacological, N471659** Paracetamol/acetaminophen253 (53.7)251 (38.1) NSAIDs201 (42.7)364 (55.2) Metamizole33 (7.0)45 (6.8) Local anesthetics13 (2.8)27 (4.1) Tramadol4 (0.8)6 (0.9) Aspirin2 (0.4)4 (0.6) Codeine2 (0.4)2 (0.3) Morphine2 (0.4)17 (2.6) Anti-depressants1 (0.2)1 (0.2) Neuromodulators-3 (0.5)[^3]

No laboratory tests were prescribed to most patients with pain (489/705; 69.4%), and laboratory tests were more often prescribed to patients aged ≥12 years (45/89; 50.6%). Complete blood count was the most often prescribed laboratory test (165/705; 23.4%) in all age groups.

Both pain and fever {#S0003-S2004}
-------------------

Among the 2117 patients analyzed, 446 (21.1%) suffered from both fever and acute pain. Current and previous treatments for fever received in patients with both acute pain and fever are presented in [Table 4](#T0004){ref-type="table"}. [[Table S9](https://www.dovepress.com/get_supplementary_file.php?f=168140.pdf)]{.ul} illustrates the treatments prescribed for fever by age group in patients with both acute pain and fever. Paracetamol/acetaminophen was prescribed in 242/356 (68.0%) and 244/439 (55.6%) patients with both acute pain and fever who received any pharmacological treatment for their fever during previous consultations and during the current consultation, respectively. NSAIDs were prescribed in 137/356 (38.5%) and 217/439 (49.4%) patients during previous and current consultations, respectively.Table 4Previous and current treatments prescribed for fever in patients with both acute pain and fever (N=446)Treatment prescribed, n (%)PreviousCurrent**Non-pharmacological, N356439** Warm water bath121 (34.0)147 (33.5) Administrate oral hydration frequently115 (32.3)214 (48.7) Remove excess clothing and linens94 (26.4)145 (33.0) Bed rest54 (15.2)100 (22.8) Ventilate room37 (10.4)72 (16.4) Other25 (7.0)17 (3.9)**Pharmacological, N356439** Paracetamol/acetaminophen242 (68.0)244 (55.6) NSAIDs137 (38.5)217 (49.4) Metamizole26 (7.3)36 (8.2) Aspirin5 (1.4)2 (0.5)[^4]

With regard to pain management in patients with both fever and acute pain ([Table 5](#T0005){ref-type="table"}), paracetamol/acetaminophen was prescribed in 182/322 (56.5%) and 172/419 (41.1%) treated patients during previous and current consultations, respectively. NSAIDs were prescribed in 138/322 (42.9%) and 219/419 (52.3%) patients during previous and current consultations, respectively. [[Table S10](https://www.dovepress.com/get_supplementary_file.php?f=168140.pdf)]{.ul} summarizes the prescribed treatments used to relieve pain in patients with both acute pain and fever, by age group.Table 5Previous and current treatments prescribed for pain in patients with both acute pain and fever (N=446)Treatment prescribed; n (%)PreviousCurrent**Non-pharmacological; N322419** Bed rest83 (25.8)131 (31.3) Other34 (10.6)38 (9.1) Massages12 (3.7)12 (2.9) Heat7 (2.2)11 (2.6) Cold8 (2.5)14 (3.3) Distraction2 (0.6)7 (1.7) Plays2 (0.6)4 (1.0) Deep breath/relaxation2 (0.6)1 (0.2) Ultrasound1 (0.3)2 (0.5)**Pharmacological; N322419** Paracetamol/acetaminophen182 (56.5)172 (41.1) NSAIDs138 (42.9)219 (52.3) Metamizole31 (9.6)41 (9.8) Local anesthetics11 (3.4)16 (3.8) Morphine2 (0.6)16 (3.8) Codeine1 (0.3)1 (0.2) Aspirin-4 (1.0) Tramadol-2 (0.5) Neuromodulators-1 (0.2)[^5]

There were no differences in age-wise trends in the management of fever and pain when data for the two were analyzed either separately (pain or fever) or together (pain and fever).

Unsatisfactory effects of treatment and unmet needs in the management of fever and acute pain {#S0003-S2005}
---------------------------------------------------------------------------------------------

[Figure 1](#F0001){ref-type="fig"} summarizes the physician-perceived reasons for unsatisfactory effects of acute pain/fever treatment. More than half (95/178; 53.4%) of the physicians reported bad treatment compliance as a reason for the unsatisfactory effect of the pain/fever treatment. [Figure 2](#F0002){ref-type="fig"} summarizes the unmet needs in fever and pain management, according to physicians' perceptions. The most common unmet needs reported by physicians were the availability of new drugs (reported by 113 or 63.5% of the physicians), a decrease in the number of daily intakes (101/178; 56.7%), and improved taste of medicines (82/178; 46.1%).Figure 1Reasons for unsatisfactory treatment effects according to physicians' perceptions.Figure 2Unmet needs in fever and pain management according to physicians' perceptions.

Country-wise analysis {#S0003-S2006}
---------------------

Few differences were observed in this study between countries regarding the use of paracetamol/acetaminophen and NSAIDs. However, the use of mercury thermometer largely varied from a low of 3.6% in Algeria to a high of 85.7% in Venezuela.

Discussion {#S0004}
==========

The current observational study was conducted to evaluate the daily practice of pediatricians in terms of acute pain and fever management in Latin America, Africa, and the Middle East. Most patients received treatment for pain and/or fever in the current as well as previous consultation; both pharmacological and non pharmacological treatments were used in their management. Finkelstein et al reported an incidence of 19--30% for fever in office-based pediatric practice.[@CIT0015] In the current study, fever was seen in 87.7% of children, and it was more frequent in younger children. This could reflect upon parental concerns about fever, which in medical literature has been called "fever phobia," resulting in more frequent visits to physicians.[@CIT0018]

Paracetamol/acetaminophen was the most widely used pharmacological agent for fever, followed by NSAIDs in the current study. This concurs with international data such as that reported by Purssell et al in a survey of 181 parents where 51% reported the use of paracetamol for home management of fever.[@CIT0019] Widespread use of ibuprofen and paracetamol has shown that they are both effective in the reduction of fever in the pediatric population.[@CIT0020] Few and minor adverse events related to a previous treatment with paracetamol were reported in this study. However, the study described in this manuscript was not aimed at or designed to assessing the safety or efficacy of any of the drugs reported on by the surveyed population.

The general lack of awareness about fever extends to the knowledge about appropriate measurement of fever intensity. Measurement of body temperature needs careful consideration as axillary and tympanic membrane temperatures have low sensitivity (50--65%);[@CIT0021] hence, appropriate temperature measurement in infants and young children is recommended to be rectal. Additionally, the use of mercury thermometer is not recommended due to mercury toxicity, and many countries have banned its medical use.[@CIT0022] In the current study, mercury thermometer was used in more than a third (34.8%) of patients, and axillary temperature was most commonly measured.

More than 80% of patients with fever had been previously advised non pharmacological treatment. Though indicated in the treatment of hyperthermia, the use of physical cooling methods remains debated in the treatment of fever because of their tendency to induce cutaneous vasoconstriction, shivering, sympathetic activation, and, most importantly, discomfort.[@CIT0023] Moreover, it has been reported that two-thirds of parents who use techniques like sponging perform the technique incorrectly, with alcohol or cool water.[@CIT0018] Hence, proper education of proximate caregivers to correctly administer treatment should be a prime concern in the management of fever.[@CIT0024]

Among one-third of all patients who had pain, paracetamol and NSAIDs were the most widely used analgesics. The American Medical Association similarly reported that acetaminophen is the most commonly used analgesic agent in pediatric practice.[@CIT0025] Our results thus suggest that there is a need for better physician awareness of available pharmacological alternatives to current drugs. Especially, given the rapid changes in nociception in the early years of development,[@CIT0026] age-appropriate therapies must be used for analgesia.[@CIT0027] Adequate detection and mitigation of pain in pediatric patients is precluded by myths, personal beliefs, and values.[@CIT0004],[@CIT0028] In addition, health care professionals may lack awareness on the neonate's capability of experiencing pain and fear about adverse effects related to analgesic use -- this hampers neonatal pain management.[@CIT0012] When convincing evidence on physical pain is lacking, health care providers tend to defer treatment.[@CIT0029] Likewise, there is widespread tendency to give an underdose of analgesics to children, often due to fear of respiratory failure.[@CIT0029] In pediatric patients, analgesia (including opioids in case of severe pain) should be prescribed when indicated during medical care as adequate treatment of pain may result in decreased clinical complications and decreased mortality.[@CIT0030]

In the current study, in contrast with the management of fever, in most patients, non pharmacological measures to alleviate pain were not used. Non pharmacological options must be considered either as substitutes or as complements. Thus, cognitive behavioral strategies that involve the use of imagery, relaxation, respiration, autohypnosis, and self-regulation can provide pain relief,[@CIT0031],[@CIT0032] and evidence-based non pharmacological strategies are reported to be frequently used and perceived as effective by the child life specialists.[@CIT0033]

Pain intensity was evaluated through various methods in our study; the most frequently used were behavioral changes, the VRS, and facial expression scales. Systematic evaluation of pain in neonatal intensive care units has been shown to improve awareness of treating pain and to increase the use of analgesics.[@CIT0034],[@CIT0035] Despite the seeming advantages of using standardized pain assessment tools, individual self-report is often favored because pain is a subjective experience. Nonetheless, it should be ensured that children, especially those in the age group of 3--7 years, are competent to provide information, and behavioral observation should be used to complement/supplement self-report when necessary.[@CIT0004] Increasingly, the management and assessment of pain by specialized pain teams is being seen as a useful approach in improving clinical outcomes in conditions involving pain.[@CIT0029],[@CIT0036]

While the current study affords us an opportunity to examine the clinical practices in terms of fever and pain management, the understanding gained is limited by the fact that a limited number of investigators from each country were selected. The sample of investigation sites in the study was not estimated on the basis of the size of the country. Thus, data from countries with larger populations might need further confirmation by larger, country-specific studies. Other limitations of the study include the inability to study the interregional variation in the patterns of prescription of analgesics, antipyretics, and NSAIDs. This is mainly due to the fact that most participating countries in this study were from Latin America and the Caribbean, and the number of countries in the other regions was too small to make comparisons between regions. However, analyses by country were conducted, and few differences were observed between the countries. This study is also limited by its cross-sectional nature and by the fact that it is based on self-reported evaluations rather than observed real-life practice. Furthermore, our data are observational and might be affected by a possible selection bias with regard to the investigation sites invited to participate. Nevertheless, in the absence of any other such real-world evidence from a large multinational study, the current data and findings are valuable evidence for both physicians and parents caring for children with fever and/or acute pain.

Conclusion and implications for practice {#S0005}
========================================

Although randomized clinical trials remain the gold standard for advancing knowledge in medicine, multinational studies of real-world data on prescription patterns, such as the present study, provide a means to better understand many aspects of fever and pain management, practice patterns, and unmet needs under daily practice conditions.

While an adequate management of fever was observed in the study, educational measures to avoid the use of mercury thermometers may be needed. Due to the complex etiology of pediatric pain, better evaluation and management of pain in pediatrics is necessary. It is also important that adequate training be provided on pain management within the undergraduate medical curriculum.
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[^1]: **Abbreviations:** BMI, Body mass index; SD, Standard deviation.

[^2]: **Notes:** Thirteen missing values were reported for patients with fever who were prescribed previous treatments, and among the remaining analyzed 1843 patients, 327 (17.7%) were not prescribed any previous treatment for their fever. A total of 39/1856 patients with fever (2.1%) were not prescribed any current treatment. Multiple pharmacological or non-pharmacological treatments were possible for each patient.

    **Abbreviation:** NSAIDs, Non-steroidal anti-inflammatory drugs.

[^3]: **Notes:** Four missing values were reported for patients with acute pain who were prescribed previous treatments, and among the remaining analyzed 701 patients, 230 (32.8%) were not prescribed any previous treatment for their pain. Three missing values were reported for patients with acute pain who were prescribed current treatments, and among the remaining analyzed 702 patients, 43 (6.1%) were not prescribed any current treatment. Multiple pharmacological or non-pharmacological treatments were possible for each patient.

    **Abbreviation:** NSAIDs, Non-steroidal anti-inflammatory drugs.

[^4]: **Notes:** A total of 7/446 patients with both acute pain and fever (1.6%) were not prescribed any current treatment for their fever. Five missing values were reported for the patients with both conditions who were prescribed previous treatments, and among the remaining analyzed 441 patients, 85 (19.3%) were not prescribed any previous treatment for their fever. Multiple pharmacological or non-pharmacological treatments were possible for each patient.

    **Abbreviation:** NSAIDs, Non-steroidal anti-inflammatory drugs.

[^5]: **Notes:** Three missing values were reported for the patients with both acute pain and fever who were prescribed current treatments for their pain, and among the remaining analyzed 443 patients, 24 (5.4%) were not prescribed any current treatment for their pain. Two missing values were reported for the patients with both acute pain and fever who were prescribed previous treatments for their pain, and among the remaining analyzed 444 patients, 122 (27.5%) were not prescribed any previous treatment for their pain. Multiple pharmacological or non-pharmacological treatments were possible for each patient.

    **Abbreviation:** NSAIDs, Non-steroidal anti-inflammatory drugs.
